In ASCVD, an inclisiran-first strategy reduced LDL-C levels and statin discontinuation at 330 d
- PMID: 39102716
- DOI: 10.7326/ANNALS-24-01206-JC
In ASCVD, an inclisiran-first strategy reduced LDL-C levels and statin discontinuation at 330 d
Abstract
Koren MJ, Rodriguez F, East C, et al. An "inclisiran first" strategy vs usual care in patients with atherosclerotic cardiovascular disease. J Am Coll Cardiol. 2024;83:1939-1952. 38593947.
Conflict of interest statement
Comment on
-
An "Inclisiran First" Strategy vs Usual Care in Patients With Atherosclerotic Cardiovascular Disease.J Am Coll Cardiol. 2024 May 21;83(20):1939-1952. doi: 10.1016/j.jacc.2024.03.382. Epub 2024 Apr 7. J Am Coll Cardiol. 2024. PMID: 38593947
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical